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Background: The purpose of this study was to validate previously published satisfaction 
scales in larger and more diversified patient populations; to expand the number of community 
pharmacies represented; to test the robustness of satisfaction measures across a broader 
demographic spectrum and a variety of health conditions; to confirm the three-factor scale 
structure; to test the relationships between satisfaction and consultation practices involving phar-
macists and pharmacy students; and to examine service gaps and establish plausible norms.
Methods: Patients completed a 15-question survey about their expectations regarding phar-
maceutical care-related activities while shopping in any pharmacy and a parallel 15 questions 
about their experiences while shopping in this particular pharmacy. The survey also collected 
information regarding pharmaceutical care consultation received by the patients and brief 
demographic data.
Results: A total of 628 patients from 55 pharmacies completed the survey. The pilot study’s 
three-factor satisfaction structure was confirmed. Overall, satisfaction measures did not differ 
by demographics or medical condition, but there were strong and significant store-to-store dif-
ferences and consultation practice advantages when pharmacists or pharmacists-plus-students 
participated, but not for consultations with students alone.
Conclusion: Patient satisfaction can be reliably measured by surveys structured around 
pharmaceutical care activities. The introduction of pharmaceutical care in pharmacies improves 
patient satisfaction. Service gap details indicated that pharmacy managers need to pay closer 
attention to various consultative activities involving patients and doctors.
Keywords: patient expectations, patient experiences, advanced pharmacy practice experience, 
medication management
Introduction
Schools of pharmacy throughout Canada and the United States have made considerable 
progress in incorporating the philosophy and practice of pharmaceutical care (PC) into 
their curricula.1,2 A key curricular reform has been to recruit experiential sites that 
support the integration of students into direct patient care activities, thereby enabling 
cultivation of PC competencies and confidence. The PC process commonly includes 
conducting assessment of patients’ medical concerns as part of new/refill prescription 
intake; nonprescription consultations; sit-down consultations for chronic diseases; 
performing individualized medication reviews; developing care plans; providing patient 
specific interventions; collaborating with other health professionals when necessary; 
and monitoring patients’ progress through follow-up care to ensure desired outcomes 
are achieved.1–3
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Several studies have demonstrated that providing PC at 
community pharmacies has significant benefits to patients, 
and that student involvement extends these benefits to wider 
patient populations who otherwise would not receive them.3–12 
Despite these advantages, the dissemination of PC services 
across community pharmacies in North America has been 
slow.13–15 One proposed approach to stimulate this transition 
is to quantify patient expectations and current satisfaction 
with such services.16,17 As part of this initiative, a three-phase 
study was initiated to: first, operationalize patient satisfaction 
with PC for community pharmacy-based advance pharmacy 
practice experiences (APPE); second, evaluate the impact of 
two community pharmacy-based APPE models on patient 
satisfaction; and third, validate the findings using larger 
and more diverse patient populations frequenting different 
varieties of community pharmacies. The results of these first 
two phases have been published elsewhere.18,19 This study 
aimed to address the third phase.
Various approaches to patient satisfaction resulting from 
community pharmacy experience have been identified and 
reviewed elsewhere.20 Notable among these are Gourlay’s 
ECHO model, Oliver’s pleasurability index, and MacKiegan 
and Larson’s two-factor model.21–23 A previously published 
paper has outlined the development of a patient satisfaction 
scale based on the Hepler and Strand PC framework.3 In that 
pilot study, patient satisfaction was operationalized around 
PC processes and activities encountered in the community 
pharmacy setting, then analyzed for validity and psychometric 
robustness. The scale was based on what patients report actu-
ally experiencing during the particular in-store experience 
contrasted against what they would expect to receive “in 
any pharmacy anywhere”. Patient responses showed clear 
distinctions between their expectations about PC-related 
transactions in any store versus their specific experiences with 
the processes and activities in this particular store. Further, 
factor analysis indicated that patients’ conceptualization of 
satisfaction focused on three themes, ie, monitoring strategies 
for medication outcomes, providing information and educa-
tion, and providing personalized collaborative and preventive 
care. Because the original pilot study had established the 
feasibility of conceptualizing and measuring patient satis-
faction in community pharmacies in terms of foundational 
notions of PC for both pharmacists and their patients, further 
development and scale validation needed to move beyond 
the proof-of-concept stage. Generalizability theory offered 
a convenient logical platform.24
To move beyond the proof-of-concept stage, a broader 
and much larger follow-up study was undertaken with the 
following five objectives: to test further previously bench-
marked satisfaction scales with much larger and more 
diversified audiences and expanded numbers of national 
pharmacy chains represented; confirm the pilot study’s 
three-factor structure of PC-based patient satisfaction; verify 
robustness of satisfaction scales among patients in a wider   
variety of pharmacies, across a broader range of patient 
demographics, and across a broad variety of disease types; 
test the relationships between “consultation intensiveness” 
and satisfaction with both pharmacist consultations and 
consultations with students on rotation; and document the 
range of “service gaps” (differences between what patients 
expect and what they experience) among the various pharma-
cies in order to provide managers with tangible information 
about how to increase patient satisfaction.
Theoretical framework
Generalizability theory as initially outlined by Cronbach et al 
is a statistical framework for conceptualizing, investigating, 
and designing reliable observations.24 It is used to determine 
the reliability (ie, reproducibility) of measurements under 
specific conditions. For any measuring scale or device to be 
robust or trustworthy, it must perform consistently across 
different “facets” – variations in person, item, or occasion 
(p, i, o) which account for who is responding (p), which scale 
items are chosen (i), and on which occasions the measure-
ments are taken (o). In short, the scale must be generalizable. 
In this larger-scale investigation, different and more varied 
facets were tested; different stores, different retail chains, 
different times and locations, wider varieties of medical 
conditions, and broader ranges of patient demographics, 
ie, gender, age, education, and income, but all with a view 
toward verifying the generalizability of a PC interpretation 
of satisfaction.
Overview
The overall goal of this study was to demonstrate that 
brief in-store surveys can provide store managers with 
tightly focused information to improve PC-based direct 
care to patients during the brief time they are transacting 
their business with pharmacists, APPE students, and other 
store personnel. To do that, the robustness and sensitivity 
of the survey needed to be first solidly documented. Thus, 
we report initially on our methods, participants, data col-
lection strategies, and analysis procedures. Next, we report 
results concerning the new participant cohort, anchored 
scale details, factorial corroboration, the robustness of the 
satisfaction scales against potentially spurious demographic 
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distractors, and finally we report on its sensitivity to the 
store-to-store differences encountered in field settings. 
Among those in-store differences are varying practices about 
structured consultations with patients regarding potential 
health issues… an essential requisite of true PC-based 
practice and a central instance of delivery of direct patient 
care. Lastly, we report on how service gaps detract from true 
PC and direct care delivery. We discuss how such scales can 
focus store managers’ attention to critical shortfalls in their 
in-store practices and we conclude with observations about 
how APPEs and clerkship students can be effective tools for 
managers to implement fully fledged PC among their stores’ 
personnel and practices.
Methods and materials
A quasi-experimental, nonequivalent comparison group 
design was used to assess patient satisfaction and the 
effects of demographics and health conditions together with 
patient consultations on their health conditions. The study 
was conducted in 2004 over an eight-month period in   British 
Columbia, Canada. Ethics approval had been previously 
obtained through the University of British Columbia’s Office 
of Research Services.
Participants
Patients throughout British Columbia frequenting APPE-
affiliated community pharmacies (national chains and inde-
pendently owned) during the period of the study were invited 
to complete a streamlined PC-based survey. Pharmacies were 
located throughout the entire province and in both urban and 
rural settings proportionate to the province’s overall popula-
tion demographics. Project staff deposited bundles of blank 
surveys at participating pharmacies together with survey 
return boxes. Pharmacists and students were instructed to 
hand surveys to all patients filling or refilling prescriptions 
and to encourage them to complete the surveys and to deposit 
them in the survey return box which was labeled to assure 
patients that their responses would be delivered directly to 
the research project office without being read by pharmacy 
personnel.
Data collection
The survey asked 15 questions representing the six PC 
domains described by Cipolle et al (developing a relation-
ship, assessing patients, clarifying the role of medications, 
developing a pharmacy care plan, working collaboratively 
with other health care providers, and providing follow-up 
to patients).3 Questions were phrased as service delivery 
features and asked patients about their expectations regarding 
PC-related activities while shopping in any pharmacy and 
an additional parallel 15 questions about their experiences 
while shopping in this particular pharmacy. Responses were 
recorded using five-point Likert letter scales of disagreement/
agreement, ie, strongly disagree, disagree, neutral, agree, 
and strongly agree. The pilot study had earlier demonstrated 
that the scale has strong reliability and validity. The overall 
expectation index had a Cronbach reliability of α = 0.89, 
while the in-store experience reliability was α = 0.94. 
As before, the survey also collected brief demographic data, 
but included new information regarding pharmacist/student 
consultations on a variety of medical conditions following 
their satisfaction reports. A research assistant entered all the 
data into Excel spreadsheets.
Analysis
Descriptive statistics (frequencies, means, and standard 
deviations) from the new study participants were summarized. 
Robustness and sensitivity were both tested as fractions of 
variance accounted for Pearson’s r2 or η ′2 by demographic 
or store factors. New factor analyses were carried out 
and from the factor structures, scale and subscale scores 
operationalized patient satisfaction measures. For the respon-
dents, paired t-tests were used to compare baseline expecta-
tions in any pharmacy with in-store experience on individual 
satisfaction items, subscale scores, and overall scale score. 
Scores indicating “service gaps” were computed as the dif-
ference between expectation and experience. For ease of 
interpretation, all computed subscale and overall scores as 
well as gap scores were transformed into scales ranging from 
1 to 5, and parallel to the original response formats.
Four levels of consultation were categorized, ie, none, 
student only, pharmacist only, or both student and pharmacist. 
Responses to expectations and experiences were compared 
for these four consultation groups using one-way analysis 
of variance and post hoc comparisons. Similar procedures 
were used to compare service gap scores across consultation 
groups and demographic factors. Throughout, statistical 
analyses were conducted using SPSS 17.0 for Windows 
(SPSS Inc, Chicago, IL).
Results
Respondents
A total of 628 patients from 55 community pharmacy stores 
representing national chains and independent pharmacies 
returned completed surveys. No precount of surveys was 
maintained; therefore, response rates cannot be determined. 
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The patient sample included 37% males and 63% females. All 
age groups, education levels, and household incomes were 
well represented. Table 1 summarizes the demographic char-
acteristics of the respondents. Most were mature, ie, in the 
40–60-year or 60–80-year age brackets with “some college 
or university” education levels, and household incomes 
averaging just under $50,000 annually.
Patients were asked whether they had received consultations 
lasting at least 15 minutes for any of seven medical condi-
tions (asthma, diabetes, heart condition, blood pressure, 
cholesterol, arthritis, osteoporosis, and “other”) and whether 
consultations had occurred with an in-store pharmacist, a 
pharmacy student, both, or neither. Table 1 reports these 
medical conditions. About a quarter of the patients did not 
answer the consultation question. Of the 464 patients (73.9%) 
who did report, the majority (61%) had had no consultation, 
while 11% each had consulted with a pharmacist only or a 
student only; 17% reported a consultation with both pharma-
cist and student. About one-quarter (24%) of patients reported 
consultations about blood pressure, while cholesterol, heart 
conditions, diabetes, and asthma were each discussed for 
about 15% of patients (Table 1).
Anchored satisfaction measures
Overall, the current study expanded by more than four-fold 
the numbers of respondents in the pilot study, nearly tripled 
the numbers of pharmacies, and doubled the numbers of 
chains represented. The expanded numbers and demographic 
ranges of respondents enabled a more definitive examina-
tion of the benefits of contrasting patient experiences in a 
particular pharmacy against what they would expect in any 
pharmacy. For all 15 items, the average respondent either 
“agreed” or “strongly agreed” that they would expect that 
feature in any pharmacy. But what they actually experienced 
in this particular pharmacy averaged nearly a half point lower 
for all items combined. Further, for all items but one, scores 
for the in-store experience were higher than the mid-scale 
“neutral/don’t care” rating.
Table  2  reports  these  item-by-item  figures  in 
descending order of the differences between expectations 
and experiences, or “service gaps”. The greatest shortfalls 
appear for shared decision-making responsibilities, 
collaboration among pharmacists, physicians, and patients, 
discussing different available options, and inquiring 
regarding concerns about medications. For only one item 
did overall patient experiences outperform expectations, 
ie, pleasant and courteous staff. And for only that single 
item was the difference nonsignificant; the shortfalls for all 
remaining 14 items were statistically significant (P , 0.001). 
Further, shortfall differences for the overall scale and its 
three factorially derived subscales were also statistically 
significant (P , 0.001).
Factorial corroboration
New factor analyses were undertaken to compare the pilot 
study’s “expect anywhere” factor structures.18 Previously, 
three factors were identified, which explained 60% of 
the common factor variance, ie, monitoring outcomes 
(five items), providing information and education (five items), 
and giving personalized, collaborative, and preventive care 
(five items).
Table 1   Demographic  characteristics  and  frequency  of 
consultation about medical condition for the total sample
Total n = 628 Percenta (n)
Gender
Male 36.9% (223)
Female 63.1% (381)
Age, years
Under 40 16.4% (96)
40 to 59 36.3% (213)
60 to 79 40.4% (237)
80 or over 6.8% (40)
Education
grade school 8.2% (46)
High school graduate 27.5% (154)
Some college/university 30.2% (169)
College/university graduate 25.5% (143)
Post-graduate degree 8.6% (48)
Household income
Under $10,000 11.1% (55)
$10,000 to $29,999 22.4% (111)
$30,000 to $49,999 32.3% (160)
$50,000 to $99,999 26.3% (130)
$100,000 or over 7.9% (39)
Number of pharmacies participating
national chains 74.5% (468)
independents 25.5% (160)
Had consultation for medical condition
Blood pressure 23.7% (149)
Cholesterol 15.8% (99)
Heart condition 14.8% (93)
Diabetes 14.3% (90)
Asthma 12.9% (81)
Arthritis 9.9% (62)
Osteoporosis 8.6% (54)
Other (multiple responses are possible) 18.0% (113)
Who was consultation with
no consultation 61.2% (284)
Pharmacist only 10.6% (49)
Student only 11.4% (53)
Both pharmacist and student 16.8% (78)
Note: aReported as valid percentages due to missing data for some variables and n 
does not equal 628.
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In this updated analysis, a principal component three-factor 
solution with equamax rotations (Kaiser-Meyer-Olkin = 0.88) 
again explained 60% of the variance, with 11 of the 15 items 
loading on the three factors in the same ways as in the pilot 
study (see Table 3). Two items shared their variance across 
two factors each, and two items loaded on different factors. 
Based on these results and slight improvements in interpret-
ability, the revised factor structure is: monitoring outcomes, 
consisting of items 5, 6, 7, and 15; providing information and 
education, consisting of items 8, 9, 10, 11, 12, 13, and 14; 
and giving personalized, collaborative and preventive care, 
consisting of items 1, 2, 3, and 4. Similarly, factor analysis 
of the “experienced in this store” items yielded three factors 
(Kaiser-Meyer-Olkin = 0.92) accounting for 68% of the com-
mon factor variance and loading on the same three factors, 
although in slightly different order. In both analyses, all 15 
items loaded on the first unrotated component confirming that 
there is a single generalized “satisfaction factor” and in both 
instances, equamax rotations resulted in more interpretable 
solutions than varimax.
For the three subscales created from the factor structure, 
reliability analysis yielded the following Cronbach’s alphas: 
monitoring outcomes, α = 0.81; information and education, 
α = 0.86; and personalized, collaborative and preventive care, 
α = 0.70. All were very similar to the values reported in the 
pilot study and all met or exceeded Nunnally’s threshold 
of 0.70. For the overall satisfaction scale consisting of all 
15 items, α = 0.90.26
generalizabiity, robustness,  
and sensitivity
Robustness and sensitivity are reciprocal concepts both 
embedded within generalizability. Robustness presumes 
that satisfaction scale measurements are not biased by 
attributes they are not intended to measure, such as gender, 
age, education, income, or disease type. Sensitivity, on the 
other hand, means that satisfaction scales do represent true 
variations in customer reports of stores which deliver better 
PC services than weaker stores, or chains which have overall 
patterns of better service delivery than others, or locations 
with better consultation practices than others.
The upper portion of Table 4 shows that the overall 
satisfaction scale, its three subscales, and service gaps are 
generally robust across different patient demographics, different 
disease types, different chains, and different pharmacy outlets. 
Mean gap scores were not significantly different across gender, 
income, or age (although the 80+ group reported lower gaps). 
Weakly significant differences (0.01 , P , 0.05) were noted 
across levels of education, with higher education (especially 
those with post-graduate training) leading to greater gap scores. 
Consultation was more effective at reducing service gaps for 
asthma, diabetes, heart conditions, and blood pressure issues, 
Table 2 Comparison of baseline expectations in any pharmacy with in-store experience (n = 628)
(Item no) Abbreviateda satisfaction questions 
(descending order of difference scores)
Baseline expectation 
(mean ± SD)
In-store experience 
(mean ± SD)
Difference = in-store baseline 
(mean ± SD)
(4) Share decision-making responsibilities 4.44 ± 0.72 3.68 ± 1.06 -0.76 ± 1.09
(12) Work with doctor and me to ensure best medications 4.21 ± 0.87 3.63 ± 1.08 -0.59 ± 1.11
(8) Discuss different medical options available 4.03 ± 0.93 3.47 ± 1.11 -0.57 ± 1.13
(3) Ask if i have any concerns about my medications 4.39 ± 0.68 3.90 ± 1.00 -0.50 ± 1.07
(5) Ask about my existing medical conditions 3.99 ± 0.92 3.56 ± 1.08 -0.45 ± 1.01
(14) Explain how to know if medications are working 4.05 ± 0.90 3.62 ± 1.10 -0.43 ± 1.10
(2) Reasonable privacy for discussions 4.59 ± 0.58 4.17 ± 0.91 -0.42 ± 1.06
(10) Develop a written care plan 3.77 ± 1.01 3.35 ± 1.11 -0.42 ± 1.16
(7) Ask me questions about my various medications 4.05 ± 0.88 3.65 ± 1.10 -0.41 ± 1.08
(13) Explain what to do if side effects occur 4.41 ± 0.73 4.01 ± 0.97 -0.40 ± 1.03
(6) Ask how well medical conditions are controlled 3.85 ± 0.93 3.47 ± 1.10 -0.37 ± 1.00
(11) Offer variety of info sources; print, video, verbal 3.83 ± 0.83 3.48 ± 1.04 -0.36 ± 1.05
(9) Explain how each medication is supposed to work 4.23 ± 0.81 4.03 ± 0.98 -0.21 ± 1.01
(15) Phone ask between refills if medications are working 3.00 ± 1.08 2.79 ± 1.18 -0.20 ± 1.10
(1) Pleasant and courteous pharmacy staff 4.68 ± 0.51 4.73 ± 0.55 +0.04 ± 0.66
Scale: Monitoring outcomes 3.72 ± 0.76 3.37 ± 0.98 -0.36 ± 0.81
Scale: information and education 4.07 ± 0.64 3.66 ± 0.85 -0.42 ± 0.79
Scale: Personalized, collaborative and preventive care 4.53 ± 0.45 4.12 ± 0.68 -0.41 ± 0.71
Overall score (mean of all 15 items) 4.10 ± 0.54 3.71 ± 0.78 -0.40 ± 0.69
Note: aRefer to Table 3 for complete questions.
Abbreviation: SD, standard deviation.
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and less so for cholesterol concerns, arthritis, and osteoporosis. 
Only minimal fractions of the scales’ variances (usually less 
than 1%–2%) can be attributed to any of these demographic 
or health conditions. In contrast, the table’s lower portion 
shows that the scales are highly sensitive to customer reports 
of satisfaction with the different pharmacies (20%+), to the 
impact of in-store consultations (10%–20%), and less so with 
the pharmacy’s affiliation to a specific chain or independent 
ownership (4%). Thus, these PC-based scales of satisfaction 
are instances of well developed scales which are sensitive to 
the attributes they are intended to measure, but robust against 
extraneous “noise”.
in-store consultations
Patient in-store satisfaction differed greatly depending on 
patient experiences with in-store consultations (Table 5). 
Of those reporting, and compared with those who received 
no consultation, satisfaction was significantly greater for 
groups who reported consultation with both pharmacists and 
students (P , 0.001) or with pharmacists alone (P , 0.001). 
Consultation with a student alone also showed higher 
mean satisfaction, but the differences were not statistically 
significant. Still, patient consultations were the exception 
not the rule; 284 reported no consultations and 164 skipped 
the question and can be presumed to have received no 
consultation, so consultations by students are not yet a general 
feature of patient interactions in stores adopting PC-based 
philosophies and practices.
Similarly, service gaps (Table 6) between what was 
expected and what was experienced was widest for no con-
sultation, narrower for student-only consultations, and still 
narrower for pharmacist-only consultations. However, for 
student-plus-pharmacist consultations (n = 78), patients on 
average reported greater overall in-store satisfaction than 
they would have expected in any pharmacy, hence the gap 
reversal was not a deficit but rather an asset.
Table 3 Factora loadings of 15 “expectation” items, sorted according to descending loading by factor
(Item no) complete satisfaction questions:  
here is what I would expect in any pharmacy
Factor 1: monitoring  
outcomes
Factor 2: information  
and education
Factor 3: personalized,   
collaborative, and  
preventive care
(A6) i expect pharmacists to ask me how well medical  
conditions are controlled
0.79
(A5) i expect pharmacists to ask me questions about  
my existing medical conditions
0.78
(A7) i expect pharmacists to ask me questions about  
the various medications i take
0.77
(A8) i expect pharmacists to discuss the different choices  
of medications available to treat my conditions
0.55 0.48
(A14) i expect pharmacists to explain to me how to know  
for sure if my medications are working
0.80
(A13) i expect pharmacists to explain what to do in case  
i have side effects from my medications
0.73
(A10) I expect pharmacists to develop a specific plan to  
solve any problem i may be having with my medications
0.72
(A12) i expect pharmacists to work with doctor and me  
to ensure i am on the right medications
0.67
(A9) i expect pharmacists to explain how each of my  
medications is supposed to help me
0.67
(A11) i expect pharmacists to offer me a choice  
of information sources; print, video, verbal
0.58
(A15) i expect pharmacists to phone me or ask me  
between refills whether my medications are working
0.44 0.55
(A2) i expect reasonable privacy when i discuss  
my health issues with a pharmacist
0.78
(A1) i expect pharmacy staff to be pleasant and  
courteous to me
0.75
(A3) i expect pharmacists to ask me if i have any  
concerns about my medications
0.53 0.54
(A4) i expect pharmacists to involve me when it  
comes to making decisions about my medications
0.44 0.45
Note: aFactor loadings less than 0.40 are suppressed.
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Tests for gender differences in service gaps showed 
essentially the same pattern for both male and female 
patients: highest gaps when no consultation occurred, slightly 
lower gaps for consultation with student only, much lower 
gaps for pharmacist only, and greater than expected satisfac-
tion for consultations with both pharmacist and student.
Similar patterns emerged for subgroups based on age, 
education, and income groups, with the following exceptions. 
For the 80+ age group, which overall reported lower gaps, 
it did not seem to matter who the consultation was with, ie, 
student or pharmacist or both, and simply having a consul-
tation reduced the service gap. Consultation effects were 
also lower for the “post-graduate” education group and the 
“over $100,000” income group. The absence of significant 
differences among consultation levels may be due to smaller 
effects or to small samples. Nor was there any association 
between disease type and consultation patterns.
Service gaps
Service gap information offers a quick and helpful diagnostic 
tool for store managers to learn which PC-related features 
of their stores are functioning properly and which features 
need attention. Few stores function perfectly, but informa-
tion from this broad sample of stores, patients, chains, and 
demographics provides some baseline information about 
what is reasonable to expect and where the most common 
sources of patient dissatisfaction lie.
Overall, service gap scores (Figure 1) across the 
55 pharmacies ranged from 1.39 (seriously under-performing, 
to the right) to -0.42 (better than expected, to the left) with 
an average of 0.46 (about a half point lower than would be 
expected in any store). Of course, any one patient might 
provide either highly complementary (-1.80) or seriously 
critical (3.33) reports of their in-store experiences, but 
stores averaged about a dozen reports each (ranging from 
only 1–2 reports to as many as 40), so most stores’ service 
gap scores represents a consensus of many patient reports. 
Of the 55 pharmacies in the study, only six performed at or 
above overall expectation. The mean gap between expected 
and experienced was 0.46 and the mode was 0.44, suggesting 
that about a half point of shortfall might be tolerated. But for 
stores with shortfalls in the 0.60s, 0.70s, 0.80s, and beyond, 
one or more things must be seriously amiss and managers 
have a responsibility to identify and correct the problems.
A closer inspection of 17 pharmacies (31%) representing 
157 patients with service gaps of 0.60 or more revealed the 
following specific problems in descending order of   severity: 
failing to share decision-making responsibilities, failing 
to discuss different treatment options available, failing to 
develop a written care plan, failing to explain what to do if 
side effects appear, failing to work with doctor and patient to 
ensure the best medications, and failing to ask about existing 
medical conditions. Slightly less critical were these four; 
failing to explain how to know if medications are working, 
failing to ask questions about various medications, failing 
to ask how well medical conditions are controlled, and 
failing to ask regarding any concerns about medications. 
Not surprisingly, patients in these pharmacies also reported 
disproportionately small numbers of consultations; student-
only 3%, pharmacist-only 6%, both student and pharmacist 
6%, and no consultation at all 65% (compared with 48% for 
the total sample of 55 stores).
Table 4 Robustness and sensitivity of pharmaceutical care-based satisfaction scales for demographic, health, and store characteristics
Overall  
satisfaction
Monitoring  
outcomes
Providing  
information 
and education
Personalized,  
collaborative 
and preventive care
Service gaps
r or ηa %b r or ηa %b r or ηa %b r or ηa %b r or ηa %b
Robustness
gender -0.03 0.10 -0.07 0.40 -0.04 0.20 0.03 0.10 -0.00 0.00
Age 0.09c 0.80 0.085c 0.70 0.102c 1.0 0.053 0.20 0.07 0.50
Education -0.14c 1.90 -0.16c 2.60 -0.15c 2.10 -0.08 0.60 -0.12c 1.30
income -0.06 0.30 -0.08 0.60 -0.05 0.20 -0.02 0.00 -0.01 0.00
Medical condition 0.10c 0.10 0.11c 0.10 0.092c 0.10 0.082c 0.10 -0.07 0.00
number of conditions -0.10 0.90 0.09 0.80 0.11 1.10 0.00 0.00 -0.08 0.50
Sensitivity
Different chains 0.21c 4.50 0.210 4.30 0.20c 4.10 0.20c 3.80 0.21c 4.50
Different stores 0.51c 25.60 0.52c 26.80 0.49c 23.70 0.47c 21.90 0.49c 23.60
Consultations 0.44c 18.20 0.44c 18.50 0.42c 17.40 0.32c 10.20 0.36c 12.50
Notes: aPearson correlations (r) are used for continuous variables and, eta (η) for discontinuous or categorical variables. bThe same coefficients are shown as percentages 
of satisfaction accounted for by gender, age, medical condition, chain, or store. cP , 0.05.
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Table 6 Effect of consultation on mean service gap scores (this store minus any store)
(Item no) abbreviated satisfaction  
questionsb
No consultation 
(mean ± SD)
Consultation by  
pharmacist only 
(mean ± SD)
Consultation by 
student only 
(mean ± SD)
Consultation by 
pharmacist and student   
(mean ± SD)
(1) Pleasant and courteous pharmacy staff -0.02 ± 0.66 -0.06 ± 0.77 -0.13 ± 0.69   0.26 ± 0.67a
(2) Reasonable privacy for discussions -0.71 ± 1.15a -0.33 ± 0.83a -0.38 ± 0.86a   0.10 ± 0.82
(3) Ask if i have any concerns about my medications -0.70 ± 1.15a -0.41 ± 1.08a -0.62 ± 0.88a -0.20 ± 0.93
(4) Share decision-making responsibilities -1.06 ± 1.18a -0.31 ± 0.77a -0.87 ± 1.00a -0.26 ± 0.91a
(5) Ask about my existing medical conditions -0.62 ± 1.02a -0.33 ± 0.88a -0.53 ± 1.08a   0.03 ± 0.94
(6) Ask how well medical conditions are controlled -0.55 ± 1.01a -0.24 ± 1.03 -0.38 ± 0.89a   0.08 ± 0.89
(7) Ask me questions about my various medications -0.59 ± 1.17a -0.20 ± 0.76 -0.55 ± 1.14a   0.12 ± 0.79
(8) Discuss different medical options available -0.84 ± 1.17a -0.33 ± 0.85a -0.89 ± 1.09a -0.05 ± 0.98
(9) Explain how each medication is supposed to work -0.36 ± 1.11a -0.12 ± 0.70 -0.19 ± 1.06   0.21 ± 0.82a
(10) Develop a written care plan -0.65 ± 1.11a -0.04 ± 0.85 -0.57 ± 1.12a   0.12 ± 1.26
(11) Offer variety of information sources; print, video, verbal -0.51 ± 1.08a -0.20 ± 0.74 -0.70 ± 1.14a   0.11 ± 0.99
(12) Work with doctor and me to ensure best medications -0.90 ± 1.15a -0.33 ± 0.94a -0.66 ± 1.21a -0.01 ± 0.89
(13) Explain what to do if side effects occur -0.59 ± 1.09a -0.22 ± 0.87 -0.40 ± 1.01a   0.01 ± 1.01
(14) Explain how to know if medications are working -0.64 ± 1.10a -0.16 ± 0.90 -0.53 ± 1.07a   0.06 ± 0.88
(15) Phone ask between refills if medications are working -0.36 ± 1.01a -0.08 ± 1.01 -0.26 ± 0.98   0.14 ± 1.37
Scale: monitoring outcomes -0.55 ± 0.77a -0.18 ± 0.64 -0.47 ± 0.81a   0.10 ± 0.75
Scale: information and education -0.65 ± 0.85a -0.23 ± 0.52a -0.59 ± 0.79a   0.06 ± 0.65
Scale: personalized, collaborative and preventive care -0.62 ± 0.74a -0.27 ± 0.52a -0.48 ± 0.58a -0.01 ± 0.58
Overall score (mean of all 15 items) -0.60 ± 0.71a -0.22 ± 0.46a -0.51 ± 0.66a   0.05 ± 0.58
Notes: aP , 0.05 differences between any store expectation and in-store experience; bRefer to Table 3 for complete questions.
Abbreviation: SD, standard deviation.
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Figure 1 Service gaps for 55 community pharmacies.
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Overall, it appears that the common thread is failure to 
integrate the patient as part of the care team, an attitude of 
“do to” rather than “do with”, and a failure to implement the 
foundational notions of PC. Further, overall service gaps of 
about a half point can likely be tolerated as stores and chains 
shift their operating philosophies to conform better to the 
principles of PC. However, for service gaps greater than a 
half point, corrective action on the part of store managers is 
probably warranted.
Discussion
This study’s overall objectives were to solidify and extend 
the insights of the earlier proof-of-concept study, that patient 
satisfaction measures could be structured on and grounded in 
the principles of PC and to document patient satisfaction as 
an additional incentive for community pharmacy managers to 
implement more PC domains into their stores’ practices.18 Pre-
vious researchers had employed varieties of other approaches, 
including: economic, clinical and humanistic;21 ideal referents 
versus market expectations;20 pleasurability;22 service experi-
ences and medication management;27 provider contrasts;26 
and managing therapy/friendly explanation factors.20–23,26,27 
“Solidify and extend” was defined to mean: larger and more 
diverse patient and community pharmacies, wider patient 
demographics, more varied patient health conditions, more 
formal tests of robustness and sensitivity, impact of in-store 
consultation practices, and the managerial utility of corrective 
information from brief patient questionnaires.
Among survey developers, it is a known hazard that 
surveys on nearly any topic can be developed, administered, 
validated, and published. However, Messick raises the addi-
tional requirement of “consequential validity” and argues 
that developers must remain mindful of the consequences of 
decisions which their survey results will inform.28 Thus, this 
study was structured to provide information directly usable 
by store managers to guide improvements to pharmacy prac-
tices that could improve the delivery of services along one or 
more of the three PC-grounded dimensions of satisfaction, ie, 
monitoring outcomes, providing information and education 
(including consultations), and giving personalized, collabora-
tive, and preventive care. The overall findings provide some 
important insights to researchers and managers alike:
•	 It is not sufficient to ask simply whether in-store services 
or practices are “satisfactory” in the abstract. Whether the 
patient’s experience was satisfactory or not depends on 
what s/he expected in the first place. Therefore, it is neces-
sary to “anchor” the experience against the background 
of expectation.
•	 Certain PC features are more “expected” than others, 
ie, pleasant and courteous staff; reasonable privacy for 
discussions, shared decision-making responsibilities 
versus phone between refills to ask if medications are 
working, developing written care plans, and being asked 
how well medical conditions are being controlled.
•	 Similarly, certain in-store experiences generate more 
satisfaction agreement than others, ie, pleasant and courte-
ous staff, reasonable privacy for discussions, explaining how 
each medication is supposed to work, explaining what to do 
if side effects occur versus phoning between refills to ask 
if medications are working, developing written care plans, 
and or discussing different medical options available.
•	 Thus pharmacists and managers are challenged to distin-
guish between what patients claim to want versus what 
conscientious PC practice mandates they should receive. 
They may not expect phone calls between refills to ask 
about medication effectiveness, nor 15-minute consulta-
tions about their medications, but the ground rules of PC-
based practice require that both must occur. Similarly, with 
respect to information and education, PC entails providing 
patients with an explanation of how each of their medica-
tion is supposed to work or developing care plans with the 
patient. In short, care involves public education and changes 
to expectations that patients may not yet be aware of.
These PC-based measures of satisfaction have now been 
tested and shown to be robust, ie, unbiased regarding gender, 
age, education, income, and health conditions, but concur-
rently sensitive to existing conditions and practices within 
individual stores, to consultation practices, and (weakly) to 
differences of membership in various pharmaceutical chains. 
Managers and pharmacists now have solid evidence that such 
satisfaction surveys can be implemented in their stores and 
they can be expected to yield helpful insights about direc-
tions for improvement.
Within community pharmacies, the adoption of PC 
remains a work-in-progress, and mobilizing initiatives to 
implement all of its domains presents an ongoing challenge. 
Schools of pharmacy occupy an advantageous position 
because they train the next generation of pharmacists, 
train the pharmacists/preceptors who supervise APPE 
students on rotations, establish syllabus requirements, 
and outline the learning requirements of students while 
on APPE rotations, thereby shifting the operating ethics 
of what a patient’s in-store experience ought to be. Even 
assessment of existing records or patient consultations to 
check for drug-related problems is not a universal practice 
in all pharmacies, nor is developing a care plan. Thus, these 
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APPE students along with their trained preceptors, can be 
an important vector in improving the routine performance 
of the profession and enhancing the expectations of their 
patients. When APPE student requirements are corrobo-
rated by patient satisfaction reports, store managers have 
increased incentives to promote adoption of PC into daily 
practice.
Previous studies have demonstrated that providing PC 
consultation either by student alone, pharmacist alone, and 
student-pharmacist teams, all contribute to identifying, 
resolving, and preventing greater numbers of drug-related 
problems.5–8,10–12 This study was unique in its aim to examine 
the impact of differences in pharmacy practice, providing PC 
or not, on patient satisfaction. The results confirm that pro-
viding PC by students alone, pharmacists alone, or teams of 
students and pharmacy preceptors results in improved patient 
satisfaction. However, a pivotal finding was that community 
pharmacies participating in PC-based APPE models which 
promote student-pharmacist collaborative PC may yield the 
greatest levels of patient satisfaction, such that the patient 
experiences actually surpass their expectations. This find-
ing confirms earlier studies that APPE students can and do 
contribute positively to reducing drug-related problems in 
community pharmacy settings and provides a strong argu-
ment that participating in APPE can add value to both the 
community pharmacy and to its patients.
Conclusion
Patient satisfaction can be reliably measured by surveys 
structured around the principles of pharmaceutical care. 
The introduction of PC into routine community pharmacy 
operations improves patient satisfaction, especially when 
accompanied by formal consultations about their medical 
conditions. Service gap details indicated that store manag-
ers need to pay closer attention to: involving patients in 
decision-making about their medications, discussing the 
choices of medications available, working with doctors 
and patients to ensure correct medication, and consulting 
with patients about their existing medical conditions and 
concerns, and taking a more proactive and consultative role 
in patient health care.
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